Presentation TCT 2013 Discontinuation of Long-Term Clopidogrel Therapy is Associated with Death and Myocardial Infarction after Saphenous Vein Graft Percutaneous Coronary Intervention Presenter: Amit Sachdeva, Sumati Bavisetty, Gerald Beckham, Albert Shen, Vicken Aharonian, Prakash Mansukhani, Gregg Stone, Martin Leon, Jeffrey Moses, Naing Moore, Ric Hyett, Richard Contreras, Somjot Brar January 31, 2013
Presentation TCT 2013 Comparison of Clopidogrel and Prasugrel in Patients with Unprotected Left main Disease Treated with Everolimus-Eluting Stents: Insight From the Florence Left Main-PCI Registry Presenter: Renato Valenti, Angela Migliorini, Guido Parodi, Ruben Vergara, Nazario Carrabba, Emilio Vincenzo Dovellini, David Antoniucci January 31, 2013
Presentation TCT 2013 Clinical impact of extended dual antiplatelet therapy after percutaneous coronary interventions in the drug-eluting stent era: a meta-analysis of randomized trials. Presenter: Salvatore Cassese, Robert Byrne, Tomohisa Tada, Lamin King, Adnan Kastrati January 31, 2013
Presentation TCT 2013 Can the Rate of Acute Stent Thrombosis with Bivalirudin Anticoagulation During Primary PCI in STEMI be Reduced with Modified Pharmacologic Regimens? Presenter: Andreas Baumbach, Harold Dauerman, Bernardo Cortese, Martial Hamon, Jayne Prats, Efthymios Deliargyris, Roxana Mehran, Gregg Stone January 31, 2013
Presentation TCT 2013 Can Amelioration of HDL-C Level by Pitavastatin Improve Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention? Presenter: Seung-Woon Rha, Byoung Geol Choi, Se Yeon Choi, Amro Elnagar, Sung Il Im, Sun Won Kim, Jin Oh Na, Seong Woo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Chang Gyu Park, Hong Seog Seo, Dong Joo Oh, Myung Ho Jeong January 31, 2013
News Daily News La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent Jason Kahn January 22, 2013
News Daily News Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type Jason Kahn January 22, 2013
Presentation Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent? Presenter: Marco Valgimigli January 16, 2013
News Daily News Predominan Factores Desconocidos en la Respuesta Variable al Clopidogrel January 16, 2013
Presentation Clopidogrel Pharmacokinetics and Pharmacodynamics Vary Widely Despite Exclusion or Control of Polymorphisms, Noncompliance, Diet, Smoking, Co-medications, and Preexistent Variability in Platelet Func Presenter: Andrew L. Frelinger January 15, 2013
News Daily News Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients Yael L. Maxwell January 13, 2013
News Daily News Las Recargas con Prasugrel son Viables tras un Pretratamiento con Clopidogrel en Pacientes víctimas de un SCA Yael L. Maxwell January 13, 2013
Presentation Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in ACS Patients Undergoing PCI Presenter: J.P. Loh January 09, 2013
News Daily News La Adenosina podría ser el Nexo de Unión entre el Ticagrelor y la Disnea Caitlin E. Cox January 09, 2013
News Daily News Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea Caitlin E. Cox January 09, 2013
Presentation Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans Presenter: A. Wittfeldt January 08, 2013
News Daily News Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico January 07, 2013
News Daily News PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event January 07, 2013
Presentation Reduction in First and Recurrent Cardiovascular Events with Ticagrelor vs. Clopidogrel Presenter: P. Kohli January 06, 2013